ID

13873

Descrição

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01313273

Link

https://clinicaltrials.gov/show/NCT01313273

Palavras-chave

  1. 13/03/2016 13/03/2016 -
Transferido a

13 de março de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Prostate Cancer NCT01313273

Eligibility Prostate Cancer NCT01313273

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven diagnosis of prostate cancer
Descrição

prostate cancer

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0600139
evidence of psa progression despite castrate levels of testosterone (<50 ng/dl) following orchiectomy or during therapy with luteinizing hormone releasing hormone agonists (lhrh-a)
Descrição

orchiectomy; luteinizing hormone releasing hormone agonists

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0029189
UMLS CUI [2]
C1518041
patients with non-metastatic or stable metastatic disease
Descrição

metastatic disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027627
chromogranin a elevation above normal range (confirmed by a second evaluation at least 1 week later) [cut off levels will be > 20 u/l for enzyme linked immunosorbent (elisa) assay and > 100 ng/ml for immunoradiometric (irma) assay]
Descrição

chromogranin; Enzyme-Linked Immunosorbent Assay; Immunoradiometric Assays

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0008586
UMLS CUI [2]
C0014441
UMLS CUI [3]
C0021073
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who according to the investigator opinion are candidates to be treated immediately with chemotherapy (e.g. docetaxel)
Descrição

chemotherapy docetaxel

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0246415
first line treatment with antiandrogen in monotherapy
Descrição

antiandrogen therapy

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0279492
visceral metastasis
Descrição

metastasis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0027627
previous or concomitant treatment with a somatostatin analogue
Descrição

concomitant treatment somatostatin analogue

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1707479
UMLS CUI [1,2]
C0732165

Similar models

Eligibility Prostate Cancer NCT01313273

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
prostate cancer
Item
histologically proven diagnosis of prostate cancer
boolean
C0600139 (UMLS CUI [1])
orchiectomy; luteinizing hormone releasing hormone agonists
Item
evidence of psa progression despite castrate levels of testosterone (<50 ng/dl) following orchiectomy or during therapy with luteinizing hormone releasing hormone agonists (lhrh-a)
boolean
C0029189 (UMLS CUI [1])
C1518041 (UMLS CUI [2])
metastatic disease
Item
patients with non-metastatic or stable metastatic disease
boolean
C0027627 (UMLS CUI [1])
chromogranin; Enzyme-Linked Immunosorbent Assay; Immunoradiometric Assays
Item
chromogranin a elevation above normal range (confirmed by a second evaluation at least 1 week later) [cut off levels will be > 20 u/l for enzyme linked immunosorbent (elisa) assay and > 100 ng/ml for immunoradiometric (irma) assay]
boolean
C0008586 (UMLS CUI [1])
C0014441 (UMLS CUI [2])
C0021073 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
chemotherapy docetaxel
Item
patients who according to the investigator opinion are candidates to be treated immediately with chemotherapy (e.g. docetaxel)
boolean
C0392920 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
antiandrogen therapy
Item
first line treatment with antiandrogen in monotherapy
boolean
C0279492 (UMLS CUI [1])
metastasis
Item
visceral metastasis
boolean
C0027627 (UMLS CUI [1])
concomitant treatment somatostatin analogue
Item
previous or concomitant treatment with a somatostatin analogue
boolean
C1707479 (UMLS CUI [1,1])
C0732165 (UMLS CUI [1,2])

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial